Practice guideline for the performance of therapy with unsealed radiopharmaceutical sources

International Journal of Radiation Oncology Biology Physics

Volumn 64, Issue 5, 2006, Pages 1299-1307

  Dillehay, Gary L ^a   Ellerbroek, Nancy A ^a   Balon, Helena ^b   Brill, David R ^c   Grigsby, Perry W ^e   MacKlis, Roger M ^e   Mauch, Peter M ^a   Mian, Tariq A ^a   Potters, Louis ^e   Silberstein, Edward B ^d   Williams, Timothy R ^e   Wong, Jeffrey C Y ^e   Gaspar, Laurie E ^a  

^a AMERICAN COLLEGE OF RADIOLOGY   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c Chambersburg Hospital   (United States)

^d UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^e American Society for Therapeutic Radiology and Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IBRITUMOMAB TIUXETAN; IODINE 131; LEXIDRONAM SAMARIUM SM 153; PHOSPHORUS 32; RADIOPHARMACEUTICAL AGENT; STRONTIUM 89; TOSITUMOMAB I 131;

ASCITES; BONE METASTASIS; BRAIN CYST; HUMAN; HYPERSENSITIVITY; HYPERTHYROIDISM; JOB PERFORMANCE; MEDICAL CARE; MEDICAL PRACTICE; MYELOPROLIFERATIVE DISORDER; NECK PAIN; NONHODGKIN LYMPHOMA; ODYNOPHAGIA; PATIENT EDUCATION; PERICARDIAL EFFUSION; PLEURA EFFUSION; POLYCYTHEMIA VERA; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE; REVIEW; THROMBOCYTOSIS;

EID: 33645347303     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.11.003     Document Type: Article

References (0)